ROIV

#497
Roivant Sciences Ltd. Common Shares
28.9400
+3.25%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
28.9400
28.9400
Jahresspanne
18.2700
29.2000
Tagesänderung
+3.25%
Monatliche Änderung
+28.91%
6 month change
+58.06%
Jahresänderung
+58.06%
Vorheriger Schlusskurs
28.0300
Open
28.9400
Bid
Ask
Low
28.9400
High
28.9400
Volumen
275
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 20.1671 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-42.04
Price to sales ratio
251.93
Dividends per share
—
Dividend yield %
—

Roivant Sciences Ltd

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Nachrichten